|
1.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2.
|
Zuckerman DS and Ryan DP: Adjuvant therapy
for pancreatic cancer: a review. Cancer. 112:243–249. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
4.
|
Denli AM, Tops BB, Plasterk RH, Ketting RF
and Hannon GJ: Processing of primary microRNAs by the
microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans.
Cell. 75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Reinhart BJ, Slack FJ, Basson M, et al:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Bloomston M, Frankel WL, Petrocca F, et
al: microRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
229:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Lee JW, Choi CH, Choi JJ, et al: Altered
microRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Budhu A, Jia HL, Forgues M, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lin SL, Chiang A, Chang D and Ying SY:
Loss of mir-146a function in hormone-refractory prostate cancer.
RNA. 14:417–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Crawford M, Brawner E, Batte K, et al:
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma
cell lines. Biochem Biophys Res Commun. 373:607–612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Huang Q, Gumireddy K, Schrier M, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hwang JH, Voortman J, Giovannetti E, et
al: Identification of microRNA-21 as a biomarker for
chemoresistance and clinical outcome following adjuvant therapy in
resectable pancreatic cancer. PloS One. 5:e106302010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Giovannetti E, Funel N, Peters GJ, et al:
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome
and pharmacologic aspects underlying its role in the modulation of
gemcitabine activity. Cancer Res. 70:4528–4538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Moriyama T, Ohuchida K, Mizumoto K, et al:
MicroRNA-21 modulates biological functions of pancreatic cancer
cells including their proliferation, invasion, and chemoresistance.
Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar
|
|
21.
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical significance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Fujioka S, Sclabas GM, Schmidt C, et al:
Function of nuclear factor kappaB in pancreatic cancer metastasis.
Clin Cancer Res. 9:346–354. 2003.PubMed/NCBI
|
|
24.
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Li Y, Vandenboom TG II, Wang Z, et al:
miR-146a suppresses invasion of pancreatic cancer cells. Cancer
Res. 70:1486–1495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Lin F, Wang X, Jie Z, et al: Inhibitory
effects of miR-146b-5p on cell migration and invasion of pancreatic
cancer by targeting MMP16. J Huazhong Univ Sci Technolog Med Sci.
31:509–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ma Y, Yu S, Zhao W, Lu Z and Chen J:
miR-27a regulates the growth, colony formation and migration of
pancreatic cancer cells by targeting Sprouty2. Cancer Lett.
298:150–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Yu J, Ohuchida K, Mizumoto K, et al:
MicroRNA, hsa-miR-200c, is an independent prognostic factor in
pancreatic cancer and its upregulation inhibits pancreatic cancer
invasion but increases cell proliferation. Mol Cancer. 9:1692010.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Wang F, Xue X, Wei J, et al: hsa-miR-520h
downregulates ABCG2 in pancreatic cancer cells to inhibit
migration, invasion, and side populations. Br J Cancer.
103:567–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Preis M, Gardner TB, Gordon SR, et al:
MicroRNA-10b expression correlates with response to neoadjuvant
therapy and survival in pancreatic ductal adenocarcinoma. Clin
Cancer Res. 17:5812–5821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Srivastava SK, Bhardwaj A, Singh S, et al:
MicroRNA-150 directly targets MUC4 and suppresses growth and
malignant behavior of pancreatic cancer cells. Carcinogenesis.
32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Yu J, Ohuchida K, Mizumoto K, Fujita H,
Nakata K and Tanaka M: MicroRNA miR-17-5p is overexpressed in
pancreatic cancer, associated with a poor prognosis, and involved
in cancer cell proliferation and invasion. Cancer Biol Ther.
10:748–757. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Muniyappa MK, Dowling P, Henry M, et al:
MiRNA-29a regulates the expression of numerous proteins and reduces
the invasiveness and proliferation of human carcinoma cell lines.
Eur J Cancer. 45:3104–3118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Yan H, Wu J, Liu W, et al: MicroRNA-20a
overexpression inhibited proliferation and metastasis of pancreatic
carcinoma cells. Hum Gene Ther. 21:1723–1734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Hamada S, Satoh K, Fujibuchi W, et al:
MiR-126 acts as a tumor suppressor in pancreatic cancer cells via
the regulation of ADAM9. Mol Cancer Res. 10:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Li W, Yuan Y, Huang L, Qiao M and Zhang Y:
Metformin alters the expression profiles of microRNAs in human
pancreatic cancer cells. Diabetes Res Clin Pract. 96:187–195. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelialmesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Xiong H, Hong J, Du W, et al: Roles of
STAT3 and ZEB1 proteins in E-cadherin down-regulation and human
colorectal cancer epithelial-mesenchymal transition. J Biol Chem.
287:5819–5832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelialmesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Spaderna S, Schmalhofer O, Wahlbuhl M, et
al: The transcriptional repressor ZEB1 promotes metastasis and loss
of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Burk U, Schubert J, Wellner U, et al: A
reciprocal repression between ZEB1 and members of the miR-200
family promotes EMT and invasion in cancer cells. EMBO Rep.
9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Wellner U, Schubert J, Burk UC, et al: The
EMT-activator ZEB1 promotes tumorigenicity by repressing
stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Torrisani J, Bournet B, du Rieu MC, et al:
let-7 microRNA transfer in pancreatic cancer-derived cells inhibits
in vitro cell proliferation but fails to alter tumor progression.
Hum Gene Ther. 20:831–844. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Ali S, Almhanna K, Chen W, Philip PA and
Sarkar FH: Differentially expressed miRNAs in the plasma may
provide a molecular signature for aggressive pancreatic cancer. Am
J Transl Res. 3:28–47. 2010.PubMed/NCBI
|
|
48.
|
Li Y, VandenBoom TG II, Kong D, et al:
Up-regulation of miR-200 and let-7 by natural agents leads to the
reversal of epithelial-to-mesenchymal transition in
gemcitabine-resistant pancreatic cancer cells. Cancer Res.
69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Wicha MS, Liu S and Dontu G: Cancer stem
cells: an old idea - a paradigm shift. Cancer Res. 66:1883–1890;
discussion. 1895–1896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Scie USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
54.
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar
|
|
56.
|
Moriyama T, Ohuchida K, Mizumoto K, et al:
Enhanced cell migration and invasion of CD133+
pancreatic cancer cells cocultured with pancreatic stromal cells.
Cancer. 116:3357–3368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
May R, Sureban SM, Lightfoot SA, et al:
Identification of a novel putative pancreatic stem/progenitor cell
marker DCAMKL-1 in normal mouse pancreas. Am J Physiol Gastrointest
Liver Physiol. 299:G303–310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Sureban SM, May R, Lightfoot SA, et al:
DCAMKL-1 regulates epithelial-mesenchymal transition in human
pancreatic cells through a miR-200a-dependent mechanism. Cancer
Res. 71:2328–2338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Tarasov V, Jung P, Verdoodt B, et al:
Differential regulation of microRNAs by p53 revealed by massively
parallel sequencing: miR-34a is a p53 target that induces apoptosis
and G1-arrest. Cell Cycle. 6:1586–1593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Bommer GT, Gerin I, Feng Y, et al:
p53-mediated activation of miRNA34 candidate tumor-suppressor
genes. Curr Biol. 17:1298–1307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Ji Q, Hao X, Zhang M, et al: MicroRNA
miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PloS One. 4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Ji Q, Hao X, Meng Y, et al: Restoration of
tumor suppressor miR-34 inhibits human p53-mutant gastric cancer
tumorspheres. BMC Cancer. 8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Bao B, Ali S, Banerjee S, et al: Curcumin
analogue CDF inhibits pancreatic tumor growth by switching on
suppressor microRNAs and attenuating EZH2 expression. Cancer Res.
72:335–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Wang Z, Li Y, Banerjee S and Sarkar FH:
Emerging role of Notch in stem cells and cancer. Cancer Lett.
279:8–12. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Demarest RM, Ratti F and Capobianco AJ:
It’s T-ALL about Notch. Oncogene. 27:5082–5091. 2008.
|
|
66.
|
Dotto GP: Notch tumor suppressor function.
Oncogene. 27:5115–5123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang
Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by
inactivation of nuclear factor-kappaB, vascular endothelial growth
factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar
|
|
68.
|
Strizzi L, Hardy KM, Seftor EA, et al:
Development and cancer: at the crossroads of Nodal and Notch
signaling. Cancer Res. 69:7131–7134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Ristorcelli E and Lombardo D: Targeting
Notch signaling in pancreatic cancer. Expert Opin Ther Targets.
14:541–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Nalls D, Tang SN, Rodova M, Srivastava RK
and Shankar S: Targeting epigenetic regulation of miR-34a for
treatment of pancreatic cancer by inhibition of pancreatic cancer
stem cells. PloS One. 6:e240992011. View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Bao B, Wang Z, Ali S, et al: Notch-1
induces epithelial-mesenchymal transition consistent with cancer
stem cell phenotype in pancreatic cancer cells. Cancer Lett.
307:26–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Matthaios D, Zarogoulidis P, Balgouranidou
I, Chatzaki E and Kakolyris S: Molecular pathogenesis of pancreatic
cancer and clinical perspectives. Oncology. 81:259–272. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Feldmann G, Dhara S, Fendrich V, et al:
Blockade of hedgehog signaling inhibits pancreatic cancer invasion
and metastases: a new paradigm for combination therapy in solid
cancers. Cancer Res. 67:2187–2196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Ferretti E, De Smaele E, Miele E, et al:
Concerted microRNA control of Hedgehog signalling in cerebellar
neuronal progenitor and tumour cells. EMBO J. 27:2616–2627. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
75.
|
Northcott PA, Fernandez LA, Hagan JP, et
al: The miR-17/92 polycistron is up-regulated in sonic
hedgehog-driven medulloblastomas and induced by N-myc in sonic
hedgehog-treated cerebellar neural precursors. Cancer Res.
69:3249–3255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Friggi-Grelin F, Lavenant-Staccini L and
Therond P: Control of antagonistic components of the hedgehog
signaling pathway by microRNAs in Drosophila. Genetics.
179:429–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
77.
|
Tsuda N, Ishiyama S, Li Y, Ioannides CG,
Abbruzzese JL and Chang DZ: Synthetic microRNA designed to target
glioma-associated antigen 1 transcription factor inhibits division
and induces late apoptosis in pancreatic tumor cells. Clin Cancer
Res. 12:6557–6564. 2006. View Article : Google Scholar
|
|
78.
|
Yu S, Lu Z, Liu C, et al: miRNA-96
suppresses KRAS and functions as a tumor suppressor gene in
pancreatic cancer. Cancer Res. 70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79.
|
Vogt M, Munding J, Gruner M, et al:
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG
methylation in colorectal, pancreatic, mammary, ovarian,
urothelial, and renal cell carcinomas and soft tissue sarcomas.
Virchows Arch. 458:313–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80.
|
Tashiro E, Tsuchiya A and Imoto M:
Functions of cyclin D1 as an oncogene and regulation of cyclin D1
expression. Cancer Sci. 98:629–635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
81.
|
Lee KH, Lotterman C, Karikari C, et al:
Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent
kinase 6 expression in pancreatic cancer. Pancreatology. 9:293–301.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
82.
|
Grewal IS and Flavell RA: CD40 and CD154
in cell-mediated immunity. Annu Rev Immunol. 16:111–135. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
83.
|
Costello RT, Gastaut JA and Olive D: What
is the real role of CD40 in cancer immunotherapy? Immunology Today.
20:488–493. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
84.
|
Mees ST, Mardin WA, Sielker S, et al:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85.
|
Kouzarides T: Histone acetylases and
deacetylases in cell proliferation. Curr Opin Genet Dev. 9:40–48.
1999. View Article : Google Scholar
|
|
86.
|
Ida K, Kitabayashi I, Taki T, et al:
Adenoviral E1A-associated protein p300 is involved in acute myeloid
leukemia with t(11;22) (q23;q13). Blood. 90:4699–4704.
1997.PubMed/NCBI
|
|
87.
|
Mees ST, Mardin WA, Wendel C, et al: EP300
- a miRNA-regulated metastasis suppressor gene in ductal
adenocarcinomas of the pancreas. Int J Cancer. 126:114–124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
